Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13895392 | 0.99 | ALDH1A1 (0.40) | ALDH1A1MAPTSMN1; SMN2PKMTHRB | |
| SCHEMBL14402085 | 0.91 | ALDH1A1 (0.44) | ALDH1A1MAPTSMN1; SMN2PKMTHRB | |
| SCHEMBL14388437 | 0.88 | PKM (0.47) | ALDH1A1MAPTSMN1; SMN2PKMTHRB | |
| SCHEMBL13895393 | 0.86 | PKM (0.48) | ALDH1A1MAPTSMN1; SMN2PKMTHRB | |
| SCHEMBL13628680 | 0.81 | ALDH1A1 (0.33) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL13889172 | 0.80 | ALDH1A1 (0.33) | ALDH1A1MAPTSMN1; SMN2MEN1KMT2A | |
| SCHEMBL4449115 | 0.75 | — | — | |
| SCHEMBL2187850 | 0.73 | — | — | |
| SCHEMBL25039172 | 0.73 | SMN1; SMN2 (0.49) | ALDH1A1MAPTSMN1; SMN2PKMTHRB | |
| SCHEMBL13628681 | 0.73 | ALDH1A1 (0.36) | ALDH1A1MAPTSMN1; SMN2PKMMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7612155-B2 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2009-11-03 | — | — | US | disclosed |
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | FUJIFILM CORPORATION (JP) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070255003-A1 | Film forming composition, insulating film formed by use of the composition, and electronic device | C1S, C1R, MLX | ALDH1A1 4507/4885MAPT 3793/4885SMN1; SMN2 2571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.